Bayer Co.LabIncubatorBerlin: Why Start-ups Choose Bayer Co.LabOne year after the inauguration of Bayer Co.Lab — the open workspace for start-ups in Berlin — it is time to take stock. European Biotechnology News Magazine spoke with tenants and with Dr Ruth … more ➔
Yumab GmbHADCAntibodies: Cornerstone of ADC precision and efficacyAntibody-drug conjugates (ADCs) hinge on the antibody, not merely the payload or linker. Antibody precision defines efficacy, safety and therapeutic window. Emerging antibody formats – bispecifics, … more ➔
Concept Heidelberg GmbHBioanalyticsFrom method validation to the life-cycleEarlier guidelines such as ICH Q2(R1) and USP , , and viewed analytical method validation as a discrete activity focused primarily on chromatographic procedures. With ICH Q14, ICH Q2(R2), and USP , … more ➔
TenthpinTransformationCDMO: An SAP S/4HANA transformation in In Life Sciences, SAP transformations for midsize CDMOs are nothing short of complex. But integrating a newly acquired site into an existing SAP landscape is a different matter entirely. At Tenthpin, … more ➔
X-act Cologne Clinical Research GmbHClinical researchData-driven excellence: the cornerstone of clinical researchEssential areas such as study planning, interpretation, regulatory guidance, and key study design decisions remain human responsibilities, although AI increasingly supports routine tasks. X-act gets … more ➔
Die Hoffotografen GmbHCell therapySolid tumours meet their matchSolid tumours pose major obstacles for cell therapies, but German-American biotech T-knife is tackling them head-on. CEO Tom Soloway and CTO Elisa Kieback share how their “supercharged” TCR-Ts are … more ➔
Boehmert & BoehmertRegulationUS-policy-made challenges for the bio-pharma sectorNew developments under the current U.S. administration may be a challenge for the pharma/biotech industry: the Inflation Reduction Act, Orange Book Challenges, Most Favored Nation Policy, and the new … more ➔
AseBio BioSpain 2025Opportunity Health SL wins start-up pitch contestOut of 43 pitches, the founders of Spanish Opportunity Health S.L. delivered the best presentation for a new life sciences product: a choking device that can potentially be used by anyone in emergency … more ➔
AseBioBioSpain 2025 Panel discussion: what drives US investments?Alongside a start-up pitch featuring 45 international participants, the second day of BioSpain 2025 (7–9 October 2025, Barcelona) offered biotech start-ups a panel discussion with prominent US investors, … more ➔
https://www.chimia.ch/chimia/article/view/2025_292BiomanufacturingBiomanufacturing in SwitzerlandSwitzerland is a key hub for biomanufacturing, with immunological products like antibodies and vaccines making up 18.5% of 2024 exports. Swiss companies drive biotech innovation and biocatalysis across … more ➔
Bayer Co.Lab
Yumab GmbH
Concept Heidelberg GmbH
Tenthpin
X-act Cologne Clinical Research GmbH
Die Hoffotografen GmbH
Boehmert & Boehmert
AseBio 
AseBio
https://www.chimia.ch/chimia/article/view/2025_292